拓新药业(301089.SZ)：预计2025年亏损5400万元–7300万元
Tuoxin Pharmaceutical Tuoxin Pharmaceutical (SZ:301089) Ge Long Hui A P P·2026-01-23 14:42

Group 1 - The company expects a loss of 54 million to 73 million yuan in 2025, with a non-recurring loss of 62 million to 84 million yuan [1] - The market environment has negatively impacted the company's sales revenue and gross margin due to fluctuations in terminal demand and declining market prices for certain raw material products [1] - The company's operational development is affected by high fixed costs during the gradual release of new production capacity from completed fundraising projects, as well as high unit costs from small-scale production of new health products set to launch in 2025 [1]

Tuoxin Pharmaceutical -拓新药业(301089.SZ)：预计2025年亏损5400万元–7300万元 - Reportify